Registration - In-house Corporation

Subject Matters

• Aboriginal Affairs
• Agriculture
• Biologics
• biotechnology
• Biotech policy
• Constitutional Issues
• Consumer Issues
• Defence
• Economy
• Education
• Employment and Training
• Energy
• Environment
• Financial Institutions
• Fisheries
• Forestry
• Government Procurement
• Health
• Immigration
• Industry
• Infrastructure
• Intellectual Property
• Internal Trade
• International Relations
• International Trade
• Justice and Law Enforcement
• Labour
• Pandemic Planning
• Regional Development
• Science and Technology
• SEBs
• Small Business
• Sports
• Subsequent Entry Biologics
• Taxation and Finance
• Transportation

Subject matters added through a monthly communication report

• Data Protection Regulations
• Financing for Emerging Biotech Companies
• Right of Appeal

Subject Matter Details

Legislative Proposal, Bill or Resolution

• Annual federal Budgets and Budget updates as it relates to the biopharmaceutical industry
• Patent Act as it relates to further changes affecting patent term restoration

Legislative Proposal, Bill or Resolution, Policies or Program

• Food and Drugs Act as it relates to modernization

Policies or Program

• Biologics and Genetic Therapies Directorate as it relates to policies affecting the review and approval of submissions
• Guidance for Industry: Issuance of Health Professional Communications and Public Communications by Market Authorization Holders and Draft Guidance Document: Triggers for Issuance of Risk Communication Documents for Marketed Health Products for Human Use with respect to communications from manufacturers, health professionals and consumers, to the public via Health Canada and manufacturers, and Product Monographs
• Health Canada International Memorandum of Understanding with respect to exchanging data and safety protocols
• Health Canada Post Notice of Compliance Change Guidance: Quality with respect to the categorization of a change and the recommended supporting data for any changes to the Quality information associated with a new drug
• Implementation of the National Pharmaceutical Strategy as it affects the industry
• Pandemic Planning as it relates to the Task Group on Antiviral Prophylaxis recommendations
• Patent Act as it relates to changes to Canada's Access to Medicines Regime
• Patented Medicine Prices Review Board in respect of proposed Pricing Guidelines
• Progressive Licensing Framework with respect to its development and government consultations
• Science and Technology Strategy as it relates to new policies for the pharmaceutical industry
• Therapeutic Products Directorate's work as it relates the Guidance for Industry: Management of Drug Submissions with respect to the review and approval of submissions

Policies or Program, Regulation

• Creation of pathways for Subsequent Entry Biologics (SEBs) pertaining to Draft Guidance for Sponsors: Information and Submission Requirements for SEBs, regulations and intellectual property policies

Regulation

• Amendments to the Food and Drugs Act Regulations as it relates to further changes to data protection
• Patent Act as it relates to Patented Medicines (Notice of Compliance) Regulations and possible changes to modernize
• User Fees Act with respect to cost recovery

Communication Techniques

• Written communication
• Oral communication

Government Institutions

• Aboriginal Affairs and Northern Development Canada
• Agriculture and Agri-Food Canada (AAFC)
• Atlantic Canada Opportunities Agency (ACOA)
• Canadian International Development Agency (CIDA)
• Canadian International Trade Tribunal (CITT)
• Canadian Space Agency (CSA)
• Canadian Transportation Agency (CTA)
• Citizenship and Immigration Canada
• Competition Tribunal (CT)
• Correctional Service of Canada (CSC)
• Environment Canada
• Federal Office of Regional Development – Quebec (FORD[Q])
• Finance Canada (FIN)
• Foreign Affairs and International Trade Canada (DFAITC)
• Health Canada (HC)
• Human Resources Development Canada (HRDC)
• Industry Canada
• Justice Canada (JC)
• Members of the House of Commons
• National Defence (DND)
• National Research Council (NRC)
• Natural Resources Canada (NRCan)
• Natural Sciences and Engineering Research Council (NSERC)
• Office of the Auditor General
• Office of the Information and Privacy Commissioner (OIPC)
• Patented Medicine Prices Review Board (PMPRB)
• Prime Minister's Office (PMO)
• Privy Council Office (PCO)
• Public Safety and Emergency Preparedness Canada (PSEPC)
• Public Service Commission of Canada (PSC)
• Public Works and Government Services Canada
• Revenue Canada (RC)
• Royal Canadian Mounted Police (RCMP)
• Senate of Canada
• Service Canada (ServCan)
• Solicitor General Canada (SGC)
• Statistics Canada (StatCan)
• Transport Canada (TC)
• Treasury Board Of Canada Secretariat (TBS)
• Veterans Affairs Canada (VAC)
• Western Economic Diversification Canada (WD)

Government institutions added through a monthly communication report

• Public Health Agency of Canada (PHAC)

Address:
2455 Meadowpine Blvd.
Mississauga, ON  L5N 6L7
Canada

Telephone number: 905-542-5555
Fax number: 905-542-7130  

Parent Company Information